Current concepts on interstitial lung disease in children

Related Experiment Video

Updated: Oct 20, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

M S Howenstine1, H Eigen

  • 1James Whitcomb Riley Hospital for Children, Indiana University School of Medicine, Indianapolis 46202-5225, USA.

Current Opinion in Pediatrics
|June 1, 1999
PubMed

Insights

Pediatric interstitial lung disease (ILD) is a rare, complex group of lung disorders in children. Research is ongoing to understand its causes, improve diagnosis, and develop targeted therapies to reduce serious illness and death.

Area of Science:

  • Pediatric Pulmonology
  • Rare Diseases
  • Respiratory Medicine

Background:

  • Pediatric interstitial lung disease (ILD) encompasses rare conditions affecting lung development and function in children.
  • Unlike adults, children require ongoing lung growth, complicating ILD management and prognosis.
  • Current knowledge regarding pathogenesis, prognosis, and treatment of pediatric ILD remains limited.

Purpose of the Study:

  • To investigate the cellular mediators and genetic factors contributing to interstitial lung damage in children.
  • To further define the various types of pediatric ILD and diagnostic modalities.
  • To advance the development of targeted therapies for pediatric ILD.

Main Methods:

  • Focus on defining cellular mediators of interstitial damage.
  • Investigating the role of viral infections and genetic predispositions.
  • Evaluating diagnostic tools including bronchoalveolar lavage, radiography, and biopsy.

Main Results:

  • Ongoing research aims to elucidate the underlying mechanisms of pediatric ILD.
  • Studies are refining the classification and diagnostic approaches for these rare conditions.
  • Efforts are directed towards identifying specific therapeutic targets.

Conclusions:

  • Understanding the unique challenges of pediatric ILD, including lung development, is crucial.
  • Multidisciplinary research is essential for improving diagnosis and treatment outcomes.
  • The ultimate goal is to reduce the significant morbidity and mortality associated with pediatric ILD.

Related Concept Videos

Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.